According to MediciNova's latest financial reports the company's current revenue (TTM) is $1 M. In 2022 the company made a revenue of N/A a decrease over the years 2021 revenue that were of $4.03 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $1 M | |
2022 | N/A | -100% |
2021 | $4.03 M | |
2020 | N/A | |
2019 | N/A | |
2018 | N/A | |
2017 | N/A | |
2016 | N/A | |
2015 | N/A | |
2014 | N/A | -100% |
2013 | $6 M | 647.99% |
2012 | $0.8 M | |
2011 | N/A | |
2010 | N/A | |
2009 | N/A | |
2006 | $0.26 M | -67.18% |
2005 | $0.8 M | 64% |
2004 | $0.49 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Novartis NVS | $51.01 B | 5,101,100.00% | ๐จ๐ญ Switzerland |
Eli Lilly LLY | $34.12 B | 3,412,310.00% | ๐บ๐ธ USA |
Sanofi SNY | $50.35 B | 5,035,891.29% | ๐ซ๐ท France |
Titan Pharmaceuticals
TTNP | $0 M | -99.90% | ๐บ๐ธ USA |
Alkermes ALKS | $1.66 B | 166,240.50% | ๐ฎ๐ช Ireland |
Teva Pharmaceutical Industries TEVA | $15.84 B | 1,584,500.00% | ๐ฎ๐ฑ Israel |